9241546956, WHO, 158 pages
The emergence of resistance to drugs used to treat tuberculosis (TB), particularly multidrug-resistant
TB (MDR-TB), has become a significant public health problem in some countries, whilst in many others
the extent of the problem is unknown. 'Guidelines for the Programmatic Management of Drug-Resistant
Tuberculosis' sets out updated recommendations for TB control programmes in low and middle income
countries based on the best current knowledge in the management of MDR-TB.
The guidelines are based on a flexible framework approach which can be adapted to suit diverse local
circumstances. The DOTS strategy remains the most effective tool to prevent the onset and dissemination
of drug resistance, and these guidelines focus on care for MDR-TB patients, in the hope and expectation
that, in future, the occurrence of massive numbers of cases can be prevented through sound TB control
practices.
No comments:
Post a Comment